CORRECTION article

Front. Aging, 23 November 2022

Sec. Interventions in Aging

Volume 3 - 2022 | https://doi.org/10.3389/fragi.2022.1086552

Corrigendum: The use of progeroid DNA repair-deficient mice for assessing anti-aging compounds, illustrating the benefits of nicotinamide riboside

  • 1. Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands

  • 2. Oncode Institute, Utrecht, Netherlands

  • 3. Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands

  • 4. Department of Hematology, Erasmus University Medical Center, Rotterdam, Netherlands

  • 5. Centre for Health Protection, National Institute for Public Health and the Environment, (RIVM), Bilthoven, Netherlands

  • 6. Faculty of Medicine, CECAD, Institute for Genome Stability in Aging and Disease, University of Cologne, Cologne, Germany

  • 7. IFOM-The FIRC Institute of Molecular Oncology, Milan, Italy

  • 8. Department of Life, Health, and Environmental Sciences, University of L'Aquila, L'Aquila, Italy

  • 9. Department of Neuroscience, Erasmus University Medical Center, Rotterdam, Netherlands

In the published article, there was an error in Figures 2, 3 as published. The panels in Figure 2 are labelled A, B, C, D, E, E, and F and in Figure 3 A, B, C, D, D, E, and F, while both were initially intended as A, B, C, D, E, F, G.

FIGURE 2

FIGURE 3

The corrected Figures 2, 3 appear below.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

aging, DNA damage repair, anti-aging interventions, pharmacological screening, dietary restriction mimetics, NAD, progeria

Citation

Birkisdóttir MB, van Galen I, Brandt RMC, Barnhoorn S, van Vliet N, van Dijk C, Nagarajah B, Imholz S, van Oostrom CT, Reiling E, Gyenis Á, Mastroberardino PG, Jaarsma D, van Steeg H, Hoeijmakers JHJ, Dollé MET and Vermeij WP (2022) Corrigendum: The use of progeroid DNA repair-deficient mice for assessing anti-aging compounds, illustrating the benefits of nicotinamide riboside. Front. Aging 3:1086552. doi: 10.3389/fragi.2022.1086552

Received

01 November 2022

Accepted

03 November 2022

Published

23 November 2022

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

3 - 2022

Updates

Copyright

*Correspondence: Wilbert P. Vermeij, ; Martijn E. T. Dollé,

This article was submitted to Interventions in Aging, a section of the journal Frontiers in Aging

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics